LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 410

Search options

  1. Article ; Online: The lowest well tolerated blood pressure: A personalized target for all?

    Verdecchia, Paolo / Angeli, Fabio / Reboldi, Gianpaolo

    European journal of internal medicine

    2024  

    Abstract: The optimal blood pressure (BP) target for prevention of cardiovascular complications of hypertension remains uncertain. Most Guidelines suggest different targets depending on age, comorbidities and treatment tolerability, but the underlying evidence is ... ...

    Abstract The optimal blood pressure (BP) target for prevention of cardiovascular complications of hypertension remains uncertain. Most Guidelines suggest different targets depending on age, comorbidities and treatment tolerability, but the underlying evidence is not strong. Results of randomized strategy trials comparing lower (i.e., more intensive) versus higher (i.e., less intensive) BP targets should drive the definition. However, these trials tested different BP targets based on systolic BP, diastolic BP or combined systolic and diastolic BP goals. Overall, the more intensive treatment targets reduced the risk of major cardiovascular complications of hypertension when compared with the less intensive targets, despite a higher incidence of unwanted effects including, but not limited to, hypotension, electrolyte abnormalities and renal dysfunction. Consequently, some Guidelines defined low BP thresholds (i.e., 120/70 mmHg) not to exceed downward because of the expectation that unwanted effects may outweigh the outcome benefits. The present review discusses the evidence underlying the choice of BP targets, which remains an important step in the management of hypertensive patients. We conclude that, on the ground of the heterogeneity of available data in support to fixed BP targets, their definition should be personalized in all patients and based on best trade-off between efficacy and safety, i.e., the lowest well tolerated BP.
    Language English
    Publishing date 2024-01-25
    Publishing country Netherlands
    Document type Journal Article
    ZDB-ID 1038679-8
    ISSN 1879-0828 ; 0953-6205
    ISSN (online) 1879-0828
    ISSN 0953-6205
    DOI 10.1016/j.ejim.2024.01.025
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Prognostic impact of hypertension grading.

    Angeli, Fabio / Verdecchia, Paolo / Reboldi, Gianpaolo

    European journal of internal medicine

    2024  

    Abstract: Background: Most Hypertension Guidelines grade hypertension according to various cut-off values. We sought to investigate the prognostic impact of Grades 1 (140-159 and/or 90-99 mmHg), 2 (160-179 and/or 100-109 mmHg) and 3 (≥180 and/or ≥110 mmHg).: ... ...

    Abstract Background: Most Hypertension Guidelines grade hypertension according to various cut-off values. We sought to investigate the prognostic impact of Grades 1 (140-159 and/or 90-99 mmHg), 2 (160-179 and/or 100-109 mmHg) and 3 (≥180 and/or ≥110 mmHg).
    Methods: We followed for an average of 10 years a cohort of 3,150 initially untreated hypertensive patients (mean age 50 years, 44 % women) with no previous cardiovascular disease at entry. All patients underwent diagnostic tests including 24-hour ambulatory blood pressure (BP) monitoring.
    Results: At entry, average clinic BP was 156/97 mmHg and average 24-hour BP was 137/87 mmHg. During follow-up, 314 patients experienced a first major cardiovascular event (composite of non-fatal myocardial infarction or stroke, cardiovascular death, or hospitalization for heart failure). Event rate was not formally dissimilar between Grade 1 and Grade 2 (0.73 vs 0.95 per 100 patient-years, respectively; p = 0.06). It was higher in Grade 3 (1.93 per 100 patient-years; p < 0.01 vs Grade 1 and Grade 2). After adjustment for a robust set of covariables, the hazard ratio was not dissimilar between Grade 1 and Grade 2 (p = 0.27), and higher in Grade 3 than in Grade 1 (p < 0.01), but the excess risk in Grade 3 was no longer significant (hazard ratio: 1.25, 95 % CI 0.87-1.78; p = 0.22) after adjustment for 24-hour ambulatory systolic BP.
    Conclusions: We were unable to find a significant difference in the relative hazard of cardiovascular events tied to hypertension Grades 1 and 2. Conversely, Grade 3 (clinic BP ≥180/110 mmHg) portends a higher cardiovascular risk, which is associated with higher levels of 24-hour ambulatory BP.
    Language English
    Publishing date 2024-04-14
    Publishing country Netherlands
    Document type Journal Article
    ZDB-ID 1038679-8
    ISSN 1879-0828 ; 0953-6205
    ISSN (online) 1879-0828
    ISSN 0953-6205
    DOI 10.1016/j.ejim.2024.04.008
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: 2023 ESH Guidelines. What are the main recommendations?

    Verdecchia, Paolo / Grossmann, Ehud / Whelton, Paul

    European journal of internal medicine

    2023  Volume 116, Page(s) 1–7

    MeSH term(s) Humans ; Hypertension ; Blood Pressure
    Language English
    Publishing date 2023-08-01
    Publishing country Netherlands
    Document type Journal Article
    ZDB-ID 1038679-8
    ISSN 1879-0828 ; 0953-6205
    ISSN (online) 1879-0828
    ISSN 0953-6205
    DOI 10.1016/j.ejim.2023.07.034
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Severe acute respiratory syndrome coronavirus 2 evolution: How mutations affect XBB.1.5 variant.

    Zappa, Martina / Verdecchia, Paolo / Angeli, Fabio

    European journal of internal medicine

    2023  Volume 112, Page(s) 128–132

    MeSH term(s) Humans ; SARS-CoV-2/genetics ; COVID-19 ; Mutation
    Language English
    Publishing date 2023-03-29
    Publishing country Netherlands
    Document type Letter
    ZDB-ID 1038679-8
    ISSN 1879-0828 ; 0953-6205
    ISSN (online) 1879-0828
    ISSN 0953-6205
    DOI 10.1016/j.ejim.2023.03.027
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: When the responsibility for a crime is shared between several actors. The case of hypertensive heart failure with preserved ejection fraction.

    Coiro, Stefano / Verdecchia, Paolo / Angeli, Fabio

    European journal of internal medicine

    2023  Volume 120, Page(s) 29–31

    MeSH term(s) Humans ; Stroke Volume ; Heart Failure ; Hypertension ; Crime
    Language English
    Publishing date 2023-11-27
    Publishing country Netherlands
    Document type Journal Article
    ZDB-ID 1038679-8
    ISSN 1879-0828 ; 0953-6205
    ISSN (online) 1879-0828
    ISSN 0953-6205
    DOI 10.1016/j.ejim.2023.11.022
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: The old and the new: The EG.5 ('Eris') sub-variant of Coronavirus.

    Zappa, Martina / Verdecchia, Paolo / Andolina, Andrea / Angeli, Fabio

    European journal of internal medicine

    2023  Volume 117, Page(s) 123–125

    MeSH term(s) Humans ; Coronavirus ; Proteins ; Coronavirus Infections
    Chemical Substances Proteins
    Language English
    Publishing date 2023-09-09
    Publishing country Netherlands
    Document type Letter
    ZDB-ID 1038679-8
    ISSN 1879-0828 ; 0953-6205
    ISSN (online) 1879-0828
    ISSN 0953-6205
    DOI 10.1016/j.ejim.2023.09.003
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: La terapia genica dell’ipertensione arteriosa: focus su zilebesiran.

    Angeli, Fabio / Zappa, Martina / Bartolini, Claudia / Verdecchia, Paolo

    Giornale italiano di cardiologia (2006)

    2023  Volume 24, Issue 12, Page(s) 948–950

    Title translation Gene therapy for hypertension: focus on zilebesiran.
    MeSH term(s) Humans ; Hypertension/drug therapy ; Antihypertensive Agents/therapeutic use ; Genetic Therapy
    Chemical Substances Antihypertensive Agents
    Language Italian
    Publishing date 2023-11-27
    Publishing country Italy
    Document type Journal Article
    ZDB-ID 2272414-X
    ISSN 1972-6481 ; 1827-6806
    ISSN (online) 1972-6481
    ISSN 1827-6806
    DOI 10.1714/4139.41339
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Rethinking the Role of the Renin-Angiotensin System in the Pandemic Era of SARS-CoV-2.

    Angeli, Fabio / Zappa, Martina / Verdecchia, Paolo

    Journal of cardiovascular development and disease

    2023  Volume 10, Issue 1

    Abstract: After assessing the levels of spread and severity of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, academic literature focused on the pathophysiology of coronavirus disease 2019 (COVID-19) [ ... ]. ...

    Abstract After assessing the levels of spread and severity of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, academic literature focused on the pathophysiology of coronavirus disease 2019 (COVID-19) [...].
    Language English
    Publishing date 2023-01-01
    Publishing country Switzerland
    Document type Editorial
    ZDB-ID 2777082-5
    ISSN 2308-3425 ; 2308-3425
    ISSN (online) 2308-3425
    ISSN 2308-3425
    DOI 10.3390/jcdd10010014
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Is the competition between variants the end of severe acute respiratory syndrome coronavirus 2 pandemic? A journey from Wuhan to XBB.1.16.

    Zappa, Martina / Verdecchia, Paolo / Angeli, Fabio

    European journal of internal medicine

    2023  Volume 113, Page(s) 13–15

    MeSH term(s) Humans ; SARS-CoV-2 ; COVID-19 ; Pandemics ; Renin-Angiotensin System ; Peptidyl-Dipeptidase A/metabolism
    Chemical Substances Peptidyl-Dipeptidase A (EC 3.4.15.1)
    Language English
    Publishing date 2023-04-19
    Publishing country Netherlands
    Document type Journal Article
    ZDB-ID 1038679-8
    ISSN 1879-0828 ; 0953-6205
    ISSN (online) 1879-0828
    ISSN 0953-6205
    DOI 10.1016/j.ejim.2023.04.016
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Hypertension and myocarditis following COVID-19 vaccination. Two sides of the coin?

    Angeli, Fabio / Reboldi, Gianpaolo / Zappa, Martina / Verdecchia, Paolo

    European journal of internal medicine

    2023  Volume 113, Page(s) 107–109

    MeSH term(s) Humans ; COVID-19/prevention & control ; COVID-19 Vaccines/adverse effects ; Myocarditis/etiology ; Renin-Angiotensin System ; Hypertension/etiology ; Vaccination/adverse effects
    Chemical Substances COVID-19 Vaccines
    Language English
    Publishing date 2023-04-28
    Publishing country Netherlands
    Document type Letter ; Comment
    ZDB-ID 1038679-8
    ISSN 1879-0828 ; 0953-6205
    ISSN (online) 1879-0828
    ISSN 0953-6205
    DOI 10.1016/j.ejim.2023.04.023
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top